DLAT promotes triple-negative breast cancer progression via YAP1 activation
Our research unveiled the significant involvement of DLAT in TNBC, along with the potential for modulating DLAT/YAP1 activity as a targeted treatment strategy for TNBC.
Authors
- Xiaochong Deng
- Danrong Ye
- Diya Liu (ORCID: https://orcid.org/0000-0002-4909-6897)
- Xuehui Wang (ORCID: https://orcid.org/0000-0001-7505-3316)
- Lin Fang (ORCID: https://orcid.org/0000-0003-2418-3617)
- Fengyuan Qian
Institutions
- Tongji University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Shanghai Tenth People's Hospital (CN)
- Guizhou Provincial People's Hospital (CN)
Publication Details
- Journal
- Cancer Biology & Therapy
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1080/15384047.2024.2421578
- Citations
- 2
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.65
Funders
- National Natural Science Foundation of China